AMPH
Price
$49.29
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
20 days until earnings call
SUPN
Price
$32.92
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
21 days until earnings call
Ad is loading...

AMPH vs SUPN

Header iconAMPH vs SUPN Comparison
Open Charts AMPH vs SUPNBanner chart's image
Amphastar Pharmaceuticals
Price$49.29
Change-$0.00 (-0.00%)
Volume$284.23K
CapitalizationN/A
Supernus Pharmaceuticals
Price$32.92
Change-$0.00 (-0.00%)
Volume$230.4K
CapitalizationN/A
View a ticker or compare two or three
AMPH vs SUPN Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AMPH vs. SUPN commentary
Oct 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and SUPN is a StrongBuy.

COMPARISON
Comparison
Oct 16, 2024
Stock price -- (AMPH: $49.29 vs. SUPN: $32.92)
Brand notoriety: AMPH and SUPN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 85% vs. SUPN: 51%
Market capitalization -- AMPH: $2.11B vs. SUPN: $1.84B
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 1 green, 4 red.
According to our system of comparison, AMPH is a better buy in the long-term than SUPN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while SUPN’s TA Score has 6 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 4 bearish.
  • SUPN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than AMPH.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а +5.25% price change this week, while SUPN (@Pharmaceuticals: Other) price change was +2.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

AMPH is expected to report earnings on Mar 12, 2025.

SUPN is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than SUPN($1.84B). SUPN has higher P/E ratio than AMPH: SUPN (1677.00) vs AMPH (16.69). SUPN YTD gains are higher at: 13.753 vs. AMPH (-20.307). AMPH has higher annual earnings (EBITDA): 240M vs. SUPN (90M). AMPH (257M) and SUPN (255M) have equal amount of cash in the bank . SUPN has less debt than AMPH: SUPN (41.5M) vs AMPH (624M). AMPH has higher revenues than SUPN: AMPH (644M) vs SUPN (608M).
AMPHSUPNAMPH / SUPN
Capitalization2.11B1.84B115%
EBITDA240M90M267%
Gain YTD-20.30713.753-148%
P/E Ratio16.691677.001%
Revenue644M608M106%
Total Cash257M255M101%
Total Debt624M41.5M1,504%
FUNDAMENTALS RATINGS
AMPH vs SUPN: Fundamental Ratings
AMPH
SUPN
OUTLOOK RATING
1..100
1513
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
3278
SMR RATING
1..100
3889
PRICE GROWTH RATING
1..100
4545
P/E GROWTH RATING
1..100
901
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (73) in the Pharmaceuticals Other industry is in the same range as SUPN (95). This means that AMPH’s stock grew similarly to SUPN’s over the last 12 months.

AMPH's Profit vs Risk Rating (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for SUPN (78). This means that AMPH’s stock grew somewhat faster than SUPN’s over the last 12 months.

AMPH's SMR Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for SUPN (89). This means that AMPH’s stock grew somewhat faster than SUPN’s over the last 12 months.

AMPH's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as SUPN (45). This means that AMPH’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for AMPH (90). This means that SUPN’s stock grew significantly faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHSUPN
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 8 days ago
72%
Declines
ODDS (%)
Bearish Trend 13 days ago
66%
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 6 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Ad is loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X66046.1250003194.750000
+5.08%
Bitcoin cryptocurrency
GME21.330.50
+2.40%
GameStop Corp
AAPL231.403.85
+1.69%
Apple
SPY584.324.74
+0.82%
SPDR® S&P 500® ETF Trust
TSLA219.161.36
+0.62%
Tesla

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with SUPN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+3.62%
SUPN - AMPH
35%
Loosely correlated
-0.24%
AMRX - AMPH
30%
Poorly correlated
+0.82%
VTRS - AMPH
29%
Poorly correlated
+0.18%
MKKGY - AMPH
27%
Poorly correlated
+0.75%
DVAX - AMPH
26%
Poorly correlated
+0.29%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with PETQ. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then PETQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-0.24%
PETQ - SUPN
42%
Loosely correlated
+0.03%
AMPH - SUPN
35%
Loosely correlated
+3.62%
DVAX - SUPN
32%
Poorly correlated
+0.29%
AMRX - SUPN
30%
Poorly correlated
+0.82%
COLL - SUPN
28%
Poorly correlated
+0.72%
More